NCT04190446View on ClinicalTrials.gov

A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

November 22, 2025

Study Completion Date

November 22, 2025

Conditions
Metastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate AdenocarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer AJCC v8
Interventions
RADIATION

Intensity-Modulated Radiation Therapy

Undergo IMRT

RADIATION

Proton Beam Radiation Therapy

Undergo proton beam radiation therapy

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Computed Tomography

Undergo CT scan

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04190446 - A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer | Biotech Hunter | Biotech Hunter